Elevated prostate specific antigen [PSA] R97.20 is a valid billable ICD-10 diagnosis code for Elevated prostate specific antigen [PSA]. It is found in the 2019 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2018 - Sep 30, 2019.
Oct 01, 2021 · 2022 ICD-10-CM Diagnosis Code R97.20: Elevated prostate specific antigen [PSA] ICD-10-CM Codes › R00-R99 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified › R97-R97 Abnormal tumor markers › R97- Abnormal tumor markers › 2022 ICD-10-CM Diagnosis Code R97.20 2022 ICD-10-CM Diagnosis Code R97.20
Oct 01, 2021 · R97.2 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. The 2022 edition of ICD-10-CM R97.2 became effective on October 1, 2021. This is the American ICD-10-CM version of R97.2 - other international versions of ICD-10 R97.2 may differ.
Rising PSA fol treatment for malignant neoplasm of prostate ICD-10-CM Diagnosis Code R79.82 [convert to ICD-9-CM] Elevated C-reactive protein (CRP) Elevated c-reactive protein ICD-10-CM Diagnosis Code R70.0 [convert to ICD-9-CM] Elevated erythrocyte sedimentation rate Elevated sedimentation rate measurement; Esr raised
Oct 01, 2021 · Free, official coding info for 2022 ICD-10-CM R97.21 - includes detailed rules, notes, synonyms, ICD-9-CM conversion, index and annotation crosswalks, DRG grouping and more. Toggle navigation. Search All ICD-10 Toggle Dropdown. ... R97.20 Elevated prostate specific antigen [PSA]
ICD-9-CM | ICD-10-CM |
---|---|
Consists of three to five digits | Consists of three to seven characters |
First character is numeric or alpha ( E or V) | First character is alpha |
Second, Third, Fourth and Fifth digits are numeric | All letters used except U |
The 2022 edition of ICD-10-CM R97.21 became effective on October 1, 2021.
R97.21 is not usually sufficient justification for admission to an acute care hospital when used a principal diagnosis. The following code (s) above R97.21 contain annotation back-references. Annotation Back-References. In this context, annotation back-references refer to codes that contain:
R97.20 is a billable diagnosis code used to specify a medical diagnosis of elevated prostate specific antigen [psa]. The code R97.20 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code R97.20 might also be used to specify conditions or terms like prostate specific antigen abnormal or raised prostate specific antigen.#N#The code R97.20 is applicable to adult patients aged 15 through 124 years inclusive. It is clinically and virtually impossible to use this code on a patient outside the stated age range.
Another test is the prostate-specific antigen (PSA) blood test. Your PSA level may be high if you have prostate cancer. It can also be high if you have an enlarged prostate (BPH) or other prostate problems. If your screening results are abnormal, your doctor may do more tests, such as an ultrasound, MRI, or a biopsy.
The adult code edits apply to patients age range is 15–124 years inclusive (e.g., senile delirium, mature cataract).
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code R97.20 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Prostate cancer - a common cancer that responds best to treatment when detected early
The prostate is the gland below a man's bladder that produces fluid for semen. Cancer screening is looking for cancer before you have any symptoms. Cancer found early may be easier to treat. There is no standard screening test for prostate cancer.
Finding prostate cancer may not improve your health or help you live longer
R97.20 is a valid billable ICD-10 diagnosis code for Elevated prostate specific antigen [PSA] . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.
A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.
NEC Not elsewhere classifiable#N#This abbreviation in the Tabular List represents “other specified”. When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code.
A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code.
Diagnosis for males only - The diagnosis code can only apply to a male patient. Questionable admission codes - Some diagnoses are not usually sufficient justification for admission to an acute care hospital. For example, if a patient is given code R030 for elevated blood pressure reading, without diagnosis of hypertension, ...